Pfizer Inc. ( PFE ) posted some pretty strong 3Q25 results, although the stock reaction was a bit dull. We saw a Non-GAAP EPS of $0.87, which beat estimates by about$0.23, and revenue of $16.65 billion, also beating forecasts by$150I hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me a ...